Immunity, Inflammation and Disease (Mar 2021)
Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review
Abstract
No abstracts available.
Immunity, Inflammation and Disease (Mar 2021)